Search

Your search keyword '"Lamerato, Lois E"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Lamerato, Lois E" Remove constraint Author: "Lamerato, Lois E"
165 results on '"Lamerato, Lois E"'

Search Results

2. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

3. Epidemiology of Respiratory Syncytial Virus in Adults and Children With Medically Attended Acute Respiratory Illness Over Three Seasons.

5. Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19--Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period--IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023

10. K‐medoids clustering of hospital admission characteristics to classify severity of influenza virus infection

11. Prevalence and Clinical Outcomes of Respiratory Syncytial Virus versus Influenza in Adults Hospitalized with Acute Respiratory Illness from a Prospective Multicenter Study

14. Comparisons of Respiratory Syncytial Virus (RSV) and Influenza: Population Characteristics and Clinical Outcomes in Hospitalized Adults

17. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma

19. Incidence and economic burden of respiratory syncytial virus among adults in the United States: A retrospective analysis using 2 insurance claims databases

21. Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021

22. Vaccine Effectiveness against COVID-19 among Symptomatic Persons Aged ≥12 Years with Reported Contact with COVID-19 Cases, February – September 2021

25. Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February–May 2021

26. mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February – May 2021

29. Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness

30. Fitness and prostate cancer screening, incidence, and mortality: Results from the Henry Ford Exercise Testing (FIT) Project

34. Abstract 5773: Cardiorespiratory fitness and PSA screening patterns in the Henry Ford FIT Project

35. Abstract 4348: Cardiorespiratory fitness levels in men who develop prostate cancer and its association with all-cause mortality

36. The association of fitness and body mass index (BMI) on all-cause mortality in cancer survivors: The Henry Ford Exercise Testing Project (The FIT Project).

38. Influenza Vaccine Effectiveness in the Inpatient Setting: Evaluation of Potential Bias in the Test-Negative Design by Use of Alternate Control Groups

41. Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population

43. A retrospective analysis of the relationship between race/ethnicity, age at delivery and the risk of gestational diabetes mellitus.

44. Influenza Vaccine Effectiveness in the Inpatient Setting: Evaluation of Potential Bias in the Test-Negative Design by Use of Alternate Control Groups.

46. Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population

48. Use of supportive care and risk of febrile neutropenia (FN) among patients receiving myelosuppressive chemotherapy for solid tumors or non-Hodgkin's lymphoma (NHL) at four US health systems.

50. Complementary and alternative medicine use and hormonal therapy initiation in women with hormone receptor-positive breast cancer: The BQUAL study.

Catalog

Books, media, physical & digital resources